PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsPeptic ulcer
MeSH D010437 - peptic ulcer
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D004378:Duodenal diseases
0 Companies
0 Drugs
Success rate
D013272:Stomach diseases
2 Companies
3 Drugs
$
Success rate
D010437: 
Peptic ulcer
76 Companies
13 Drugs
$
Success rate
D004381:Duodenal ulcer
121 Companies
21 Drugs
$
Success rate
D004942:Peptic esophagitis
75 Companies
7 Drugs
$
Success rate
D010439:Peptic ulcer perforation
0 Companies
0 Drugs
Success rate
D013276:Stomach ulcer
126 Companies
20 Drugs
$
Success rate
D015043:Zollinger-ellison syndrome
118 Companies
16 Drugs
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
50%
3/6
Phase 2
90%
9/10
Phase 3
65%
20/31
Approved: 7Overall Success rate: 29%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AstraZeneca
Budesonide,
Formoterol,
Formoterol fumarate dihydrate,
Glycopyrrolate,
Terfenadine,
Antacid,
Bolus,
Ssri,
Evidence
Novartis
Glycopyrrolate,
Indacaterol
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use